These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 7974497

  • 1. Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans.
    Corley RA, Bormett GA, Ghanayem BI.
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):61-79. PubMed ID: 7974497
    [Abstract] [Full Text] [Related]

  • 2. Physiologically based modeling of 2-butoxyethanol disposition in rats following different routes of exposure.
    Shyr LJ, Sabourin PJ, Medinsky MA, Birnbaum LS, Henderson RF.
    Environ Res; 1993 Nov; 63(2):202-18. PubMed ID: 8243415
    [Abstract] [Full Text] [Related]

  • 3. Determination of age and gender differences in biochemical processes affecting the disposition of 2-butoxyethanol and its metabolites in mice and rats to improve PBPK modeling.
    Corley RA, Grant DM, Farris E, Weitz KK, Soelberg JJ, Thrall KD, Poet TS.
    Toxicol Lett; 2005 Mar 28; 156(1):127-61. PubMed ID: 15705493
    [Abstract] [Full Text] [Related]

  • 4. Toxicokinetics of inhaled 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in F344 rats and B6C3F1 mice.
    Dill JA, Lee KM, Bates DJ, Anderson DJ, Johnson RE, Chou BJ, Burka LT, Roycroft JH.
    Toxicol Appl Pharmacol; 1998 Dec 28; 153(2):227-42. PubMed ID: 9878593
    [Abstract] [Full Text] [Related]

  • 5. Physiologically based pharmacokinetic modelling of human exposure to 2-butoxyethanol.
    Franks SJ, Spendiff MK, Cocker J, Loizou GD.
    Toxicol Lett; 2006 Apr 10; 162(2-3):164-73. PubMed ID: 16246510
    [Abstract] [Full Text] [Related]

  • 6. Physiologically based pharmacokinetic model for chronic inhalation of 2-butoxyethanol.
    Lee KM, Dill JA, Chou BJ, Roycroft JH.
    Toxicol Appl Pharmacol; 1998 Dec 10; 153(2):211-26. PubMed ID: 9878592
    [Abstract] [Full Text] [Related]

  • 7. Mode of action of butoxyethanol-induced mouse liver hemangiosarcomas and hepatocellular carcinomas.
    Klaunig JE, Kamendulis LM.
    Toxicol Lett; 2005 Mar 28; 156(1):107-15. PubMed ID: 15705491
    [Abstract] [Full Text] [Related]

  • 8. NTP Toxicology and Carcinogenesis Studies 2-Butoxyethanol (CAS NO. 111-76-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 2000 Mar 28; 484():1-290. PubMed ID: 12571679
    [Abstract] [Full Text] [Related]

  • 9. Rat erythrocyte morphological changes after gavage dosing with 2-butoxyethanol: a comparison with the in vitro effects of butoxyacetic acid on rat and human erythrocytes.
    Udden MM.
    J Appl Toxicol; 2000 Mar 28; 20(5):381-7. PubMed ID: 11139168
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of 2-butoxyethanol-induced hemangiosarcomas.
    Corthals SM, Kamendulis LM, Klaunig JE.
    Toxicol Sci; 2006 Aug 28; 92(2):378-86. PubMed ID: 16675516
    [Abstract] [Full Text] [Related]

  • 11. Physiologically based pharmacokinetics and the dermal absorption of 2-butoxyethanol vapor by humans.
    Corley RA, Markham DA, Banks C, Delorme P, Masterman A, Houle JM.
    Fundam Appl Toxicol; 1997 Oct 28; 39(2):120-30. PubMed ID: 9344624
    [Abstract] [Full Text] [Related]

  • 12. A human exposure study to investigate biological monitoring methods for 2-butoxyethanol.
    Jones K, Cocker J.
    Biomarkers; 2003 Oct 28; 8(5):360-70. PubMed ID: 14602521
    [Abstract] [Full Text] [Related]

  • 13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA.
    Toxic Rep Ser; 1999 Aug 28; (59):1-66, A1-E7. PubMed ID: 11803702
    [Abstract] [Full Text] [Related]

  • 14. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.
    Dallas CE, Chen XM, Muralidhara S, Varkonyi P, Tackett RL, Bruckner JV.
    Environ Res; 1994 Oct 28; 67(1):54-67. PubMed ID: 7925194
    [Abstract] [Full Text] [Related]

  • 15. Metabolism and disposition of ethylene glycol monobutyl ether (2-butoxyethanol) in rats.
    Ghanayem BI, Burka LT, Sanders JM, Matthews HB.
    Drug Metab Dispos; 1987 Oct 28; 15(4):478-84. PubMed ID: 2888620
    [Abstract] [Full Text] [Related]

  • 16. Metabolism of butoxyethanol in excised human skin in vitro.
    Traynor MJ, Wilkinson SC, Williams FM.
    Toxicol Lett; 2008 Apr 01; 177(3):151-5. PubMed ID: 18314281
    [Abstract] [Full Text] [Related]

  • 17. Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats.
    Hays SM, Elswick BA, Blumenthal GM, Welsch F, Conolly RB, Gargas ML.
    Toxicol Appl Pharmacol; 2000 Feb 15; 163(1):67-74. PubMed ID: 10662606
    [Abstract] [Full Text] [Related]

  • 18. Percutaneous penetration and metabolism of 2-butoxyethanol.
    Lockley DJ, Howes D, Williams FM.
    Arch Toxicol; 2004 Nov 15; 78(11):617-28. PubMed ID: 15455191
    [Abstract] [Full Text] [Related]

  • 19. Metabolic basis of ethylene glycol monobutyl ether (2-butoxyethanol) toxicity: role of alcohol and aldehyde dehydrogenases.
    Ghanayem BI, Burka LT, Matthews HB.
    J Pharmacol Exp Ther; 1987 Jul 15; 242(1):222-31. PubMed ID: 3612528
    [Abstract] [Full Text] [Related]

  • 20. A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: tissue distribution and CYP1A induction.
    Kedderis LB, Mills JJ, Andersen ME, Birnbaum LS.
    Toxicol Appl Pharmacol; 1993 Jul 15; 121(1):87-98. PubMed ID: 8337704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.